One day, probably in the next year or two, a company will claim it has put the first artificial-intelligence-designed ...

The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...

Akeso, Inc. (9926.HK) announced that its supplemental New Drug Application (sNDA) for gumokimab (AK111), a novel humanized anti-IL-17A monoclonal antibody for the treatment of active ankylosing ...

Learn how pH-sensitive dye detection supports reliable ADC internalization assays and insight into cellular uptake mechanisms ...

A look at the clinical progress of anti-Aβ monoclonal antibodies and how precision delivery is shaping the next generation of ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma, biotech, and industrial biology. Ainnocence is expanding partnerships, ...

Explore the transformative potential of bispecific antibodies in multiple myeloma, offering hope for improved patient ...

The leaders of Chugai Pharmaceutical are tired of their company not getting its due. At the J.P. | The leaders of Chugai ...

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

The oncology market in the United States was estimated at $81.34 billion in 2025 and is expected to reach $211.78 billion by ...

Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...